A team of researchers has developed a breakthrough technology that can be used to discriminate cancerous prostate cells in bodily fluids from those that are healthy. While the new technology is years away from use in a clinical setting, the researchers are nonetheless confident that it will be useful in developing a microdevice that will help in understanding when prostate cancer will metastasize, or spread to other parts of the body.